EP1992618A1 — Polycyclic cinnamide derivative
Assigned to Eisai R&D Management Co Ltd · Expires 2008-11-19 · 17y expired
What this patent protects
Disclosed is a compound represented by the formula (I): or a pharmacologically acceptable salt thereof, wherein Ar 1 represents an imidazolyl group which may be substituted by a C1-6 alkyl group, or the like, Ar 2 represents a phenyl group which may be substituted by a C1…
USPTO Abstract
Disclosed is a compound represented by the formula (I): or a pharmacologically acceptable salt thereof, wherein Ar 1 represents an imidazolyl group which may be substituted by a C1-6 alkyl group, or the like, Ar 2 represents a phenyl group which may be substituted by a C1-6 alkoxy group, or the like, X 1 represents a double bond or the like, and Het represents an imidazolyl group which may be substituted by a C1-6 alkyl group, or the like. The compound or the salt is effective as a therapeutic or prophylactic agent for a disease associated with Aβ.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.